Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Apex Healthcare Bhd's 3-Year ROIIC % for the quarter that ended in Dec. 2024 was 8.10%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Apex Healthcare Bhd's 3-Year ROIIC % or its related term are showing as below:
XKLS:7090's 3-Year ROIIC % is not ranked
in the Medical Distribution industry.
Industry Median: 2.295
vs XKLS:7090: 8.10
Apex Healthcare Bhd (XKLS:7090) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Apex Healthcare Bhd 3-Year ROIIC % Related Terms
Apex Healthcare Bhd 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7090 vs MCK, COR, CAH: 3-Year ROIIC % Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd 3-Year ROIIC % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Apex Healthcare Bhd (XKLS:7090) has a 3-Year ROIIC % of 8.10 as of Dec. 2024. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Apex Healthcare Bhd and its competitors. This is 19% below median its historical median of 10.02. Over the past decade, Apex Healthcare Bhd's 3-Year ROIIC % has ranged from 4.38 to 34.51.
Is Apex Healthcare Bhd's 3-Year ROIIC % too high?
Apex Healthcare Bhd's current 3-Year ROIIC % of 8.10 is 19% below median its 10-year median of 10.02. Over the past 10 years, this metric has ranged from a low of 4.38 to a high of 34.51. The Medical Distribution industry median 3-Year ROIIC % is 2.30. Apex Healthcare Bhd's value of 8.10 is 252.9% above this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's 3-Year ROIIC % compare to MCK and COR?
Apex Healthcare Bhd's 3-Year ROIIC % of 8.10 can be compared against companies in the Medical Distribution industry. The industry median 3-Year ROIIC % is 2.30. Apex Healthcare Bhd's value of 8.10 is 252.9% above this benchmark. Historically, Apex Healthcare Bhd's own 3-Year ROIIC % has ranged from 4.38 to 34.51 over the past decade. While the company's 10-year median is 10.02 vs. the industry median of 2.30, Apex Healthcare Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Distribution company?
The median 3-Year ROIIC % among Medical Distribution companies is 2.30, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current 3-Year ROIIC % of 8.10 is 252.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median 3-Year ROIIC % is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current 3-Year ROIIC % is 8.10, which is 19% below median its own 10-year median of 10.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current 3-Year ROIIC % of 8.10. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current 3-Year ROIIC % is 8.10, which is 19% below median its 10-year median of 10.02 and 252.9% above the Medical Distribution industry median of 2.30. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current 3-Year ROIIC % is 8.10 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
3-Year ROIIC %: 8.10 (19% below median its 10-year median of 10.02)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 252.9% above the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
